Marshall Wace North America’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-43,441
| Closed | -$566K | – | 1474 |
|
|
2020
Q3 | $566K | Sell |
43,441
-65,999
| -60% | -$860K | ﹤0.01% | 942 |
|
|
2020
Q2 | $1.24M | Buy |
+109,440
| New | +$1.24M | 0.01% | 706 |
|
|
2019
Q3 | – | Sell |
-74,267
| Closed | -$2.06M | – | 1456 |
|
|
2019
Q2 | $2.06M | Buy |
74,267
+73,132
| +6,443% | +$2.03M | 0.01% | 559 |
|
|
2019
Q1 | $38K | Sell |
1,135
-142,802
| -99% | -$4.78M | ﹤0.01% | 1306 |
|
|
2018
Q4 | $4.18M | Buy |
+143,937
| New | +$4.18M | 0.04% | 274 |
|
|
2018
Q2 | – | Sell |
-129,466
| Closed | -$3.83M | – | 1579 |
|
|
2018
Q1 | $3.83M | Buy |
+129,466
| New | +$3.83M | 0.02% | 629 |
|
|
2017
Q4 | – | Sell |
-119,017
| Closed | -$4.29M | – | 1522 |
|
|
2017
Q3 | $4.29M | Buy |
+119,017
| New | +$4.29M | 0.03% | 589 |
|
|
2013
Q4 | $2.64M | Buy |
+125,799
| New | +$2.64M | 0.06% | 254 |
|